TCK-276

· Teijin America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TCK-276, covering 2024-10-15 to 2024-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis [Phase 1]

See pricing